| 
 | 
 | 
 | 
 | 
Inactive Indication-  | 
Drug Highest PhasePhase 1  | 
First Approval Ctry. / Loc.-  | 
First Approval Date-  | 
 / Not yet recruitingPhase 1 A Phase 1 Randomized, Single-Blind, Three-Arm, Staggered Parallel Study to Assess the Safety, Tolerability, and Pharmacokinetics of Atorvo+™ in Healthy Adult Participants
A Phase 1 study will assess the safety, tolerability, and pharmacokinetics of Atorvo+™ in healthy adult participants.
.
100 Clinical Results associated with Indication Bioscience LLC
0  Patents (Medical) associated with Indication Bioscience LLC
100 Deals associated with Indication Bioscience LLC
100 Translational Medicine associated with Indication Bioscience LLC